Home › Funds › Clearline Capital LP › ADMA
Clearline Capital LP position in ADMA
ADMA BIOLOGICS INC · Health Care
Clearline Capital LP reported holding 1,334,725 shares of ADMA (ADMA BIOLOGICS INC) in its Q2 2026 13F filing — a position valued at US$11.2M, representing 0.67% of its reported portfolio and ranking #44 among its reported holdings. Clearline Capital LP has disclosed ADMA holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Clearline Capital LP's ADMA position evolved
Clearline Capital LP first disclosed a stake in ADMA in Q1 2026 at 556,054 shares (US$5.0M). The position peaked in Q2 2026 at 1,334,725 shares, worth US$11.2M. Across 2 filings, Clearline Capital LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,334,725 shares valued at US$11.2M — an increase of 778,671 shares quarter over quarter.. Notable position changes include a 140% increase in Q2 2026 (shares rose 20% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 556.05K | $5.01M | New |
| Q2 2026 | 1.33M | $11.17M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ADMA and 13F data
ADMA (ADMA BIOLOGICS INC) is a Health Care company. 18 other funds we track also report a position in ADMA — the largest reported positions include Rubric Capital Management LP (US$78.2M), B Group, Inc. (US$27.3M), Duquesne Family Office LLC (US$23.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ADMA
- Rubric Capital Management LP 9.34M sh · $78.17M · Q2 2026
- B Group, Inc. 3.26M sh · $27.31M · Q2 2026
- Duquesne Family Office LLC 2.78M sh · $23.30M · Q2 2026
More on Clearline Capital LP
FAQ
How long has Clearline Capital LP held ADMA?
Clearline Capital LP has disclosed ADMA holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Clearline Capital LP's current position in ADMA?
As of Q2 2026, Clearline Capital LP holds 1.33M shares of ADMA (ADMA BIOLOGICS INC), valued at $11.17M, representing 0.67% of its reported portfolio and ranking #44.
Has Clearline Capital LP been buying or selling ADMA?
In the latest 13F filing (Q2 2026), Clearline Capital LP increased its position in ADMA. The position peaked in Q2 2026 at 1.33M shares.
Which other funds hold ADMA?
Other major institutional holders of ADMA include Rubric Capital Management LP, B Group, Inc., Duquesne Family Office LLC, among 18 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.